Detalles de la búsqueda
1.
Posttreatment nonalcoholic fatty liver disease fibrosis scores for predicting liver-related complications in patients with chronic hepatitis C receiving direct-acting antiviral agents.
J Viral Hepat
; 29(9): 785-794, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35657121
2.
Liver and Spleen Stiffness Surveillance Through Elastography During and After Direct-Acting Antiviral Therapy in Patients With Chronic Hepatitis C.
J Ultrasound Med
; 41(5): 1169-1177, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-34415630
3.
Performance of Acoustic Radiation Force Impulse Elastography for Staging Liver Fibrosis in Patients With Chronic Hepatitis C After Viral Eradication.
Clin Infect Dis
; 70(1): 114-122, 2020 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30816416
4.
Rapid decline of noninvasive fibrosis index values in patients with hepatitis C receiving treatment with direct-acting antiviral agents.
BMC Gastroenterol
; 19(1): 63, 2019 Apr 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-31029101
5.
Stratification of hepatocellular carcinoma risk through modified FIB-4 index in chronic hepatitis B patients on entecavir therapy.
J Gastroenterol Hepatol
; 34(2): 442-449, 2019 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-29968933
6.
Trajectories of serum hepatitis B surface antigen kinetics in patients with chronic hepatitis B receiving long-term nucleos(t)ide analogue therapy.
Liver Int
; 38(4): 627-635, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28857411
7.
Evaluation of dose-efficacy of sorafenib and effect of transarterial chemoembolization in hepatocellular carcinoma patients: a retrospective study.
BMC Gastroenterol
; 16: 50, 2016 Apr 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-27117280
8.
Prediction model of hepatocellular carcinoma in patients with hepatitis B virus-related compensated cirrhosis receiving antiviral therapy.
Am J Cancer Res
; 13(2): 526-537, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36895986
9.
Combined CRAFITY score and α-fetoprotein response predicts treatment outcomes in patients with unresectable hepatocellular carcinoma receiving anti-programmed death-1 blockade-based immunotherapy.
Am J Cancer Res
; 13(2): 654-668, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36895987
10.
Rather than interleukin-27, interleukin-6 expresses positive correlation with liver severity in naïve hepatitis B infection patients.
Liver Int
; 32(6): 928-36, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22230324
11.
Effects of patient factors on noninvasive liver stiffness measurement using acoustic radiation force impulse elastography in patients with chronic hepatitis C.
BMC Gastroenterol
; 12: 105, 2012 Aug 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-22877310
12.
Long-term surveillance of liver histological changes in chronic hepatitis C patients completing pegylated interferon-α plus ribavirin therapy: an observational cohort study.
Ther Adv Chronic Dis
; 13: 20406223211067631, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35070254
13.
Combined Liver Stiffness and Α-fetoprotein Further beyond the Sustained Virologic Response Visit as Predictors of Long-Term Liver-Related Events in Patients with Chronic Hepatitis C.
Can J Gastroenterol Hepatol
; 2022: 5201443, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35837486
14.
Diagnostic Potential of Low Serum Platelet, Albumin and Prolong PT-INR for Overactive Bladder and Nocturia in Chronic Hepatitis-Related Liver Cirrhosis.
J Clin Med
; 10(13)2021 Jun 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-34198972
15.
Do peripartum and postmenopausal women with primary liver cancer have a worse prognosis? A nationwide cohort in Taiwan.
World J Hepatol
; 13(11): 1766-1776, 2021 Nov 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-34904044
16.
On-Treatment Albumin-Bilirubin Grade: Predictor of Response and Outcome of Sorafenib-Regorafenib Sequential Therapy in Patients with Unresectable Hepatocellular Carcinoma.
Cancers (Basel)
; 13(15)2021 Jul 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-34359658
17.
Alpha-fetoprotein response predicts treatment outcomes in patients with unresectable hepatocellular carcinoma receiving immune checkpoint inhibitors with or without tyrosine kinase inhibitors or locoregional therapies.
Am J Cancer Res
; 11(12): 6173-6187, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-35018250
18.
Prognostic roles of diabetes mellitus and hypertension in advanced hepatocellular carcinoma treated with sorafenib.
PLoS One
; 15(12): e0244293, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33382703
19.
Predictors of response and survival in patients with unresectable hepatocellular carcinoma treated with nivolumab: real-world experience.
Am J Cancer Res
; 10(12): 4547-4560, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33415018
20.
On-Treatment Changes in FIB-4 and 1-Year FIB-4 Values Help Identify Patients with Chronic Hepatitis B Receiving Entecavir Therapy Who Have the Lowest Risk of Hepatocellular Carcinoma.
Cancers (Basel)
; 12(5)2020 May 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32392752